{"id":"aa2bfdbc-f1db-581d-b0a2-fc1eade8820e","stable_key":"aad5a443-96e9-52eb-963a-812e90f9f896:lycopene-igfbp","predicate":"increased","statement":"Lycopene increased membrane-associated IGF-binding proteins without changing IGF-I receptor number or affinity.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"ef2993cb-7dc3-5de4-b593-3fad115802b9","mechanism_event_label":"The experiment points to altered signal regulation rather than fewer receptors.","subject":{"id":"0b16e027-7a68-55ae-8e33-eae8b5cd1e9e","slug":"lycopene","display_name":"Lycopene","entity_type_key":"small_molecule"},"object":{"id":"a1351774-d22b-5987-94d1-74eeea611fa2","slug":"breast-cancer-membrane-igfbp","display_name":"Membrane-associated IGF-binding proteins in MCF7 cells","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"ef2993cb-7dc3-5de4-b593-3fad115802b9","stable_key":"aad5a443-96e9-52eb-963a-812e90f9f896:lycopene-igfbp-event","event_type":"biochemical_relationship","label":"The experiment points to altered signal regulation rather than fewer receptors.","description":"Lycopene increased membrane-associated IGF-binding proteins without changing IGF-I receptor number or affinity.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"1d558783-9f80-531e-b09f-4c69e08ac426","slug":"irs1","display_name":"Human insulin receptor substrate 1 / IRS1","entity_type_key":"protein"},"role":"intracellular_relay","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"d240f5b5-d225-5f4a-ab28-8070ccb52870","slug":"igf1r","display_name":"Human insulin-like growth factor 1 receptor / IGF1R","entity_type_key":"protein"},"role":"growth_factor_receptor","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"0b16e027-7a68-55ae-8e33-eae8b5cd1e9e","slug":"lycopene","display_name":"Lycopene","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"a1351774-d22b-5987-94d1-74eeea611fa2","slug":"breast-cancer-membrane-igfbp","display_name":"Membrane-associated IGF-binding proteins in MCF7 cells","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/lycopene-research/10798222.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"f9229468bbed86c3c4fdbb24f80d139f5cac41e1692195090d19a195bcd144e8\", \"start_char\": 0, \"end_char\": 1731, \"text_sha256\": \"f9229468bbed86c3c4fdbb24f80d139f5cac41e1692195090d19a195bcd144e8\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Growth-factor stimulation and signaling assays","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"IGF-I stimulation with lycopene exposure","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Cell-line mechanism; not proof of lowered human serum IGF-I or cancer treatment.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Lycopene research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"lycopene","display_name":"Lycopene","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human MCF7 breast cancer cells","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The experiment points to altered signal regulation rather than fewer receptors.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[lycopene-p10798222] Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. (2000). https://pubmed.ncbi.nlm.nih.gov/10798222/ DOI: 10.1207/s15327914nc3601_14","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"IRS1 phosphorylation, AP-1 and cell cycle","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"a7857aac-57a4-5bd2-9adb-b9f2a2466f88","evidence_kind":"source_excerpt","locator":"Lines 689-700","start_line":689,"end_line":700,"excerpt":"### lycopene-igfbp\nLycopene increased membrane-associated IGF-binding proteins without changing IGF-I receptor number or affinity.\nCondition category: normal\nnutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: The experiment points to altered signal regulation rather than fewer receptors.\norganism: Human MCF7 breast cancer cells\ntissue_or_cell_type: IRS1 phosphorylation, AP-1 and cell cycle\nexperimental_model: Growth-factor stimulation and signaling assays\nlimitations: Cell-line mechanism; not proof of lowered human serum IGF-I or cancer treatment.\nexposure: IGF-I stimulation with lycopene exposure\nevidence_span: {\"source_cache\": \"artifacts/lycopene-research/10798222.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"f9229468bbed86c3c4fdbb24f80d139f5cac41e1692195090d19a195bcd144e8\", \"start_char\": 0, \"end_char\": 1731, \"text_sha256\": \"f9229468bbed86c3c4fdbb24f80d139f5cac41e1692195090d19a195bcd144e8\"}\n[lycopene-p10798222] Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. (2000). https://pubmed.ncbi.nlm.nih.gov/10798222/ DOI: 10.1207/s15327914nc3601_14","model_system":"Growth-factor stimulation and signaling assays","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [lycopene-p10798222] Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. (2000). https://pubmed.ncbi.nlm.nih.gov/10798222/ DOI: 10.1207/s15327914nc3601_14","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"d1e09874-8bde-548f-9664-26ad5eedb3c7","stable_key":"import-aad5a443-96e9-52eb-963a-812e90f9f896","title":"Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"9a53dd877de8b71d446f741026477c0fd70a38edac89f6f25339a371a627a59a","revision_id":"2e68d88d-a689-5959-9f9c-1552dd089c22","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}